Doctor profile · Federal record
Dr. Andrew Marple, M.D., PH.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Sarasota, FL
- NPI 1083093769
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 11 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
5951 Cattleridge Ave
Sarasota, FL 342326063
(941) 200-1125
fax (941) 200-1126
Credentials & registration
- NPI registered
- May 2015 — 11 yrs on file
- Profile last updated
- August 12, 2025
- Year of graduation
- 2015 — 11 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Florida #ME150864
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1083093769. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
281,384
Distinct HCPCS
10
Medicare allowed
$3,973,941
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 142,800 | 113 | $1 | |
J9271 |
Injection, pembrolizumab, 1 mg | 30,000 | 16 | $54 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 23,580 | 11 | $47 | |
J1453 |
Injection, fosaprepitant, 1 mg | 19,652 | 27 | $0 | |
J9267 |
Injection, paclitaxel, 1 mg | 13,741 | 11 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 12,661 | 33 | $23 | |
Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 8,290 | 19 | $8 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 4,785 | 60 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 3,290 | 48 | $1 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 2,362 | 565 | $8 |
In context: peer comparison
Among 4 peers in Sarasota Hematology & Oncology Physician, average services per provider: 2,973. This provider delivers 95× the peer median.Open Payments
Industry payments received
All-time total
$1,199
Transactions
41
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lilly USA, LLC | 8 | $206.34 | |
| Novartis Pharmaceuticals Corporation | 8 | $137.85 | |
| Celgene Corporation | 4 | $125.40 | |
| Genzyme Corporation | 1 | $121.84 | |
| Pfizer INC. | 5 | $94.40 | |
| Merck Sharp & Dohme LLC | 2 | $57.47 | |
| Incyte Corporation | 2 | $52.11 | |
| Myriad Genetic Laboratories, INC. | 2 | $46.54 | |
| Accord Healthcare, INC. | 2 | $45.42 | |
| Janssen Biotech, INC. | 2 | $34.99 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $26.61 | |
| AstraZeneca Pharmaceuticals Lp | 1 | $26.09 | |
| Amneal Pharmaceuticals LLC | 1 | $25.63 | |
| Array Biopharma INC | 1 | $21.85 | |
| Daiichi Sankyo INC. | 1 | $21.66 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
861
Patients
323
Total drug cost
$40,558
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 198 | 68 | $4,851 |
| Tamoxifen Citrate | Generic | 102 | 30 | $3,392 |
| Acyclovir | Generic | 84 | 20 | $1,018 |
| Letrozole | Generic | 64 | 24 | $1,767 |
| Dexamethasone | Generic | 57 | 36 | $1,875 |
| Hydroxyurea | Generic | 49 | 14 | $1,622 |
| Prochlorperazine Maleate | Generic | 47 | 31 | $655 |
| Oxycodone Hcl | Generic | 43 | 18 | $617 |
| Tramadol Hcl | Generic | 38 | 22 | $251 |
| Prednisone | Generic | 36 | 13 | $223 |
Frequently asked questions
What is Dr. Andrew Marple's medical specialty?
Dr. Andrew Marple practices Hematology & Oncology Physician in Sarasota, FL.
Where does Dr. Andrew Marple practice?
Dr. Andrew Marple practices at 5951 Cattleridge Ave, Sarasota, FL 342326063. Office phone: 9412001125.
What is Dr. Andrew Marple's NPI?
Dr. Andrew Marple's National Provider Identifier (NPI) is 1083093769, issued by NPPES.
Does Dr. Andrew Marple accept Medicare assignment?
Yes. Dr. Andrew Marple accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Andrew Marple commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144). Source: CMS Medicare Physician & Other Practitioners file.